Calvin Blissett on X
$6m market cap, covered by cash. In liquidation with an asset at least worth $6m likely $13m, they invest ~15m in it. This is what young Buffett thrived on $SFES
OTC
Safeguard Scientifics INC
SFES
2 stories
$11M Market cap · 2026-11-11
Get SFES news in Claude, ChatGPT or your own code. See plans
Calvin Blissett on X
$SFES: 6.8m Mcap in liquidation, cash around 5.2m, invested 12.6m in 2011 in essentially last remaining asset Prognos, invested another 3m in 2023. Prognos is a healthcare data platform whose customers include 25 of top 30 pharma manufacturers 3 of top 5 are customers, can query data on 325m patients, Stake worth around 13.3m based on 2x revenue valuation for Prognos. BroadOak invested in Prognos Nov 12 2025. Stake marked to 3m in 2022, LeadIQ est revenue for Prognos at 25-50m. At December 31, 2024, SFES said it and its subsidiaries had approximately: $284M of federal net operating and capital-loss carryforwards, including approximately $63M with an indefinite life.
